The 9th Edition of International Conference on Clinical and Translational Oncology (ICTO 2026) will be held from October 8–10, 2026, in Tokyo, Japan. Organized as a hybrid event, ICTO 2026 supports both onsite and online participation, enabling global engagement in cancer research and clinical oncology. The conference is framed around the theme “From Prevention to Survivorship: A Cancer Care Continuum,” highlighting integrated approaches across all stages of cancer care.

Scientific sessions examine cancer biology, cancer genetics and genomics, and molecular mechanisms underlying tumor development. The program also addresses cancer detection and diagnosis, therapeutic strategies, translational cancer research, and clinical trials. Dedicated sessions on prevention, epidemiology, palliative care, and supportive oncology emphasize patient-centered and population-based perspectives. Survivorship and long-term care discussions focus on improving quality of life and post-treatment outcomes.

ICTO 2026 provides an academic platform for advancing evidence-based cancer research and promoting multidisciplinary collaboration across oncology disciplines.